ReviewEndocrine journal2026

Sintilimab-related fulminant autoimmune diabetes mellitus manifesting as diabetic ketoacidosis and rare insulin resistance: A case report and literature review.

Junhui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.